What you're forgetting is that the short-term potential upside with this much greater than RAC. RAC needs to go through P1 and P2 trials which will take years. All going well, ILA's P2 trial could wrap up in Q1 next year. ILA should start to re-rate as the P2 trial progresses. If the drug works we will see significant gains here
Ann: Application for quotation of securities - ILA, page-25
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $25.45M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 16.5¢ | $11.26K | 65.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16408 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 16300 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ILA (ASX) Chart |